Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: January 2010
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Monsanto Co. et al. v. Slusser 4:10-cv-00075; filed January 14, 2010 in the Eastern District of Missouri • Plaintiffs: Monsanto Co.; Monsanto Technology,…
-
January 20, 2010 – "Are Genes Patentable?" (Intellectual Property Litigation Committee, American Bar Association) – Los Angeles & San Francisco January 21, 2010 – "Are Genes Patentable?" (Intellectual Property Litigation Committee, American Bar Association) – Birmingham, Boston, Philadelphia & Pittsburgh January 20-21, 2010 – Life Sciences IP Due Diligence (American Conference Institute) – New York,…
-
The Center for Business Intelligence (CBI) will be holding its 4th Summit on Biosimilars and Follow-on Biologics on March 18-19, 2010 in Washington, DC. At the Summit, CBI's faculty will offer presentations on the following topics: • Understand the developing biosimilars framework in the United States and European Union;• Biologics similarity — How will this…
-
The Intellectual Property Litigation Committee of the American Bar Association (ABA) Section of Litigation will be holding a number of luncheon roundtable discussions at various locations around the country to address the question: "Are Genes Patentable?" Roundtables have been scheduled on the following dates at the following locations: • January 20, 2010 – Los Angeles…
-
Fish & Richardson and the Berkeley Center for Law & Technology will be holding the Bay Area Pharma and Life Sciences IP Summit in San Mateo, CA on February 4, 2010. Registration for the event opens at 11:30 am (PT), and at noon, Suzanne Michel, Deputy Director for the Office of Policy Planning at the…
-
By Donald Zuhn — On Tuesday, the American Innovators for Patent Reform (AIPR) announced that it was joining with the Small Business Coalition on Patent Legislation in opposing patent reform legislation currently before Congress. The AIPR specifically opposes the inclusion of apportionment of damages, post-grant opposition, and first-to-file provisions in any patent reform bill…
-
By Sarah Fendrick — The U.S. Patent and Trademark Office published a notice in the Federal Register last month (74 Fed. Reg. 67987) in which the Office announced that it is considering modifications to rules governing the practice before the Board of Patent Appeals and Interferences (BPAI) in ex parte patent appeals. The USPTO…
-
By Donald Zuhn — On Monday, the American Antitrust Institute (AAI) sent a letter to Speaker of the House Nancy Pelosi (D-CA) and Senate Majority Leader Harry Reid (D-NV), urging the House and Senate to include provisions in their health care reform bills that would prohibit exclusion payments in pharmaceutical patent settlements. These payments,…
-
By James DeGiulio — Industry investor and analyst Steven Burrill (at right), CEO of Burrill & Co., reports that a record $55.8 billion was raised by the biotech industry in 2009, which constitutes an 85 percent increase over the $30.1 billion recorded in 2008. Mr. Burrill noted that these results were driven by $37…
-
Now, L.A. Times Gets It Wrong on Gene Patenting By Kevin E. Noonan — Maybe it is just the state of newspapers in the 21st Century — a 19th Century medium supplanted by technology that is more immediate, extensive, comprehensive, and relevant. Or maybe it is the pressure of deadlines and "getting the story,"…
Patent Docs 